New Strategies for HER2-Positive Breast Cancer: Moving Current Therapies Into Earlier Settings
Tue, Feb 17
|Zoom
Hosted by Med Learning Group Presented by Neil Lyengar, MD, Department of Hematology and Medical Oncology, Associate Professor, Emory University School of Medicine, Atlanta, GA
Time & Location
Feb 17, 2026, 6:30 PM – 7:30 PM
Zoom
About The Event
A Grand Round Series entitled “New Strategies for HER2-Positive Breast Cancer: Moving Current Therapies Into Earlier Settings”
Hosted by Med Learning Group
Presented by Neil Lyengar, MD, Department of Hematology and Medical Oncology, Associate Professor, Emory University School of Medicine, Atlanta, GA
Learning objectives:
Summarize the evidence for emerging treatment strategies for HER2-positive BC and current treatment recommendations.
Apply the evidence for the clinical use of HER2-directed ADCs in distinct breast cancer patient groups, including those with CNS involvement, HR-positive status, and prior endocrine therapy